Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Reply to: “NNMT aggravates hepatic steatosis but alleviates liver injury in alcoholic liver disease” and “Two sides of NNMT in alcoholic and non-alcoholic fatty liver development”

Journal of Hepatology(2021)10.1016/j.jhep.2021.01.034Source: DataRank Database

Reply to: “NNMT aggravates hepatic steatosis but alleviates liver injury in alcoholic liver disease” and “Two sides of NNMT in alcoholic and non-alcoholic fatty liver development” is a research paper published in Journal of Hepatology (2021). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Topics (5)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Jun Wang ORCID,Alexandra Griffiths ORCID,Zhenyuan Song ORCID,Qing Song ORCID

Live enrichment

PubMed:33529671

NIAAA NIH HHS

Grant: R01 AA026603

NIAAA NIH HHS

Grant: R21 AA025363

National Institutes of Health

MeSH Terms

LiverHumansLiver Diseases, AlcoholicNicotinamide N-MethyltransferaseNon-alcoholic Fatty Liver Disease